Oxford University’s Medical Sciences Division today partnered with Muscular Dystrophy UK to develop the multi-million pound Oxford Neuromuscular Translational Research Centre.
The centre, which involves Professor Kevin Talbot from NDCN, aims to bring new treatments to neuromuscular disease patients more quickly and is part of an investment from MDUK of over £4.5 million into five new transformational commitments.